Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study.
COVID-19
disease severity
female
mortality
outcomes
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
08
03
2021
received:
19
01
2021
accepted:
09
03
2021
pubmed:
13
3
2021
medline:
9
6
2021
entrez:
12
3
2021
Statut:
ppublish
Résumé
Biological sex could affect the natural history of severe acute respiratory syndrome coronavirus 2 infection. We enrolled all COVID-19 patients admitted to two COVID-19 hospitals in Milan in a prospective observational study. The primary outcome was death during the study period and the secondary outcome was critical disease at hospital admission. The association(s) between clinically relevant, noncollinear variables, and the primary outcome was assessed with uni- and multivariable Logistic regression models. A total of 520 patients were hospitalized of whom 349 (67%) were males with a median age 61 (interquartile range: 50-72). A higher proportion of males presented critically ill when compared to females (30.1% vs. 18.7%, p < .046). Death occurred in 86 (24.6%) males and 27 (15.8%) females (p = .024). In multivariable analysis age (per 10 years more) (adjusted odds ratio [AOR]: 1.83 [95% confidence interval {CI}: 1.42-2.35], p < .0001), obesity (AOR: 2.17 [95% CI: 1.10-4.31], p = .026), critical disease at hospital admission (AOR 6.34 [95% CI: 3.50-11.48], p < .0001) were independently associated to higher odds of death whereas gender was not. In conclusion, a higher proportion of males presented critically ill at hospital admission. Age, critical disease at hospital admission, obesity, anemia, D-dimer, estimated glomerular filtration rate, lactate dehydrogenase, and creatine kinase predicted death in hospitalized COVID-19 patients.
Identifiants
pubmed: 33710652
doi: 10.1002/jmv.26933
pmc: PMC8250512
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
4597-4602Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Lancet Glob Health. 2021 Jan;9(1):e14-e15
pubmed: 33160453
J Infect. 2020 Dec;81(6):e10-e12
pubmed: 32961253
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
Pharmacol Res. 2020 Aug;158:104931
pubmed: 32446978
J Med Virol. 2021 Jan;93(1):151-152
pubmed: 32603509
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Clin Microbiol Infect. 2021 Jan 20;:
pubmed: 33359539
J Med Virol. 2021 Mar;93(3):1421-1427
pubmed: 32776534
Intern Emerg Med. 2021 Jun;16(4):1051-1060
pubmed: 33175297
JMIR Public Health Surveill. 2020 Sep 18;6(3):e21866
pubmed: 32650305
Vaccines (Basel). 2020 Aug 23;8(3):
pubmed: 32842505
BMJ Evid Based Med. 2020 Dec 11;:
pubmed: 33310766
J Med Virol. 2020 Nov;92(11):2684-2692
pubmed: 32497297
J Med Virol. 2021 Jul;93(7):4597-4602
pubmed: 33710652
Vaccines (Basel). 2020 Sep 16;8(3):
pubmed: 32947988